Exact Mass: 408.077558
Exact Mass Matches: 408.077558
Found 252 metabolites which its exact mass value is equals to given mass value 408.077558,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Khelloside
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents > D011564 - Furocoumarins C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
Antibiotic MM4550
C13H16N2O9S2 (408.02972059999996)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
4-Methoxybenzenepropanol 1-(2-sulfoglucoside)
4-Methoxybenzenepropanol 1-(2-sulfoglucoside) is found in herbs and spices. 4-Methoxybenzenepropanol 1-(2-sulfoglucoside) is a constituent of fennel (Foeniculum vulgare) Constituent of fennel (Foeniculum vulgare). 4-Methoxybenzenepropanol 1-(2-sulfoglucoside) is found in herbs and spices.
2-Ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
Arteflene
C19H18F6O3 (408.11600699999997)
Ethyl biscoumacetate
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
Omapatrilat
riboflavin thiamine
C17H20N4O6S (408.11035000000004)
Dehydroamorphigenin
3,5,7,4-Tetrahydroxy-3-(5-formyl-2-hydroxyphenyl)flavanone
Rhinacanthin D
A carboxylic ester obtained by the formal condensation of 2-hydroxy-3-(3-hydroxy-2,2-dimethylpropyl)naphthalene-1,4-dione with 1,3-benzodioxole-5-carboxylic acid. Isolated from Rhinacanthus nasutus, it exhibits antiviral activity.
Villosol
10,11-Dimethoxy-3,3-dimethyl-3H-pyrano[2,3:7,8][1]benzopyrano[3,2-b][1,5]benzodioxepin-7(14H)-one
Amorpholone
Torosaflavone C
Dehydrotoxicarol
Isorobustin 4-methyl ether
3,6-Dimethoxy-6,6-dimethyl-3,4-methylenedioxypyrano[2,3:7,8]flavone
Ferrugone
Ichthynone
Flufenpyr-ethyl
CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4560; ORIGINAL_PRECURSOR_SCAN_NO 4556 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4526; ORIGINAL_PRECURSOR_SCAN_NO 4524 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4508; ORIGINAL_PRECURSOR_SCAN_NO 4505 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4549; ORIGINAL_PRECURSOR_SCAN_NO 4546 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4526; ORIGINAL_PRECURSOR_SCAN_NO 4523 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4501; ORIGINAL_PRECURSOR_SCAN_NO 4498 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9316; ORIGINAL_PRECURSOR_SCAN_NO 9312 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9375; ORIGINAL_PRECURSOR_SCAN_NO 9372 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9348; ORIGINAL_PRECURSOR_SCAN_NO 9345 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9386; ORIGINAL_PRECURSOR_SCAN_NO 9384 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9363; ORIGINAL_PRECURSOR_SCAN_NO 9362 CONFIDENCE standard compound; INTERNAL_ID 185; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9405; ORIGINAL_PRECURSOR_SCAN_NO 9404
Metrafenone
C19H21BrO5 (408.05722760000003)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3063
3,5,7-Trihydroxy-2,3-dihydro-2-(2,2-dihydroxy-5-formyl[1,1-biphenyl]-5-yl)-4H-1-benzopyran-4-one
3,5-dihydroxy-2-[(4-hydroxyphenyl)carbonyl]phenyl beta-D-glucopyranoside|iriflophenone 2-O-beta-D-glucopyranoside|iriflophenone 2-O-beta-glucopyranoside
lindleyanin|rel-(1R,2R.2aS.9bR)-1,2,2a,9b-tetrahydro-9-metoxy-1-(7-methoxy-1,3-benzodioxol-5-yl)-2-methyl-3H-cyclobuta[c]furo[3,2-g][1]benzopyran-3-one
3,5,7,4,5-pentahydroxy-6-[1-(p-hydroxy-phenyl)ethyl]flavanone
4-O-beta-D-glucopyranosyl-2,3,6-trihydroxybenzophenone|prunifloroside C
9-[(2,3-Dihydro-6-hydroxy-2-(hydroxymethyl)-3-benzofuranyl)oxy]3,10-dihydroxy-6H-dibenzo[b,d]pyran-6-one
3-(6-Bromo-1H-indole-3-yl)-6-(1H-indole-3-yl)piperazine-2-one
2-C-beta-D-xylopyranosyl-1,3,4,6,7-pentahydroxyxanthone|aquilarixanthone
2,4,6,3-tetrahydroxybenzophenone 4-O-beta-D-glucopyranoside|3,5-dihydroxy-4-(3-hydroxybenzoyl)phenyl beta-D-glucopyranoside|rhodanthenone A
2,4,3-trihydroxybenzophenone-6-O-beta-glucopyranoside|3,4,6-trihydroxy-benzophenone-2-O-beta-D-glucopyranoside
3,5,4-trihydroxy-4-methoxy-2-O-beta-D-xylosylbenzophenone
(E)-4-(3-(4-hydroxy-3-methoxyphenyl)acryloyloxy)-2-(methoxycarbonyl)-7-oxooxepane-4-carboxylic acid|paederoxepane B
2-methyl pyromeconic acid 3-O-beta-D-glucopyranoside-6-(O-4-hydroxybenzoate)
2.3,4,5,6-pentahydroxybenzophenone-2-O-alpha-L-rhamnopyranoside|petiolin F
3,3,10,10-Tetramethyl-5,8,13-trihydroxy-10H-dipyrano[3,2-a:2,3-i]xanthene-14(3H)-one
4-O-beta-D-glucopyranosyl-2,6,4-trihydroxybenzophenone|4-O-??-D-Glucopyranosyl-2,6,4-trihydroxybenzophenone|iriflophenone 4-O-beta-D-glucopyranoside
5,7,4-trihydroxy-6,8,3,6-tetramethoxy-2,3-dihydroflavonol
3-chloro-9beta,15-dihydroxy-8beta-tiglinoyloxy-dehydrleucodin
C20H21ClO7 (408.09757460000003)
ACon1_001328
Iriflophenone 3-C-glucoside is a natural product found in Aquilaria sinensis with data available. Iriflophenone 3-C-β-D-glucopyranoside, isolated from Cyclopia genistoides, has antioxidant activity[1]. Iriflophenone 3-C-β-D-glucopyranoside, isolated from Cyclopia genistoides, has antioxidant activity[1].
6a,12a-Didehydroamorphigenin
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.283 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.284 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.281
(4-hydroxyphenyl)-[2,4,6-trihydroxy-3-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl]methanone
C19H20O10_(4-Methoxy-5-oxo-5H-furo[3,2-g]chromen-7-yl)methyl beta-D-glucopyranoside
C18H20N2O9_2,4(1H,3H)-Pyrimidinedione, 1-[3-O-(4-hydroxy-2-methoxy-6-methylbenzoyl)-alpha-D-ribofuranosyl]
C18H20N2O9 (408.11687500000005)
C18H20N2O9_Uridine, 2-(4-hydroxy-2-methoxy-6-methylbenzoate)
C18H20N2O9 (408.11687500000005)
(1s)-1,5-anhydro-1-[2,4,6-trihydroxy-3-(4-hydroxybenzoyl)phenyl]-d-glucitol
[(2R,3S,4R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 4-hydroxy-2-methoxy-6-methylbenzoate
C18H20N2O9 (408.11687500000005)
[(2R,3R,4R,5R)-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] 4-hydroxy-2-methoxy-6-methylbenzoate
C18H20N2O9 (408.11687500000005)
(4-hydroxyphenyl)-[2,4,6-trihydroxy-3-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl]methanone [IIN-based: Match]
[(2R,3S,4R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 4-hydroxy-2-methoxy-6-methylbenzoate_major
C18H20N2O9 (408.11687500000005)
(1s)-1,5-anhydro-1-[2,4,6-trihydroxy-3-(4-hydroxybenzoyl)phenyl]-d-glucitol_major
Cys Cys Pro Ser
Cys Cys Ser Pro
Cys Asp Asp Gly
Cys Asp Gly Asp
Cys Gly Asp Asp
Cys Pro Cys Ser
Cys Pro Ser Cys
Cys Ser Cys Pro
Cys Ser Pro Cys
Asp Cys Asp Gly
Asp Cys Gly Asp
Asp Asp Cys Gly
Asp Asp Gly Cys
Asp Gly Cys Asp
Asp Gly Asp Cys
Gly Cys Asp Asp
Gly Asp Cys Asp
Gly Asp Asp Cys
Pro Cys Cys Ser
Pro Cys Ser Cys
Pro Ser Cys Cys
Ser Cys Cys Pro
Ser Cys Pro Cys
Ser Pro Cys Cys
His-Met-OH
C17H20N4O6S (408.11035000000004)
4-Methoxybenzenepropanol 1-(2-sulfoglucoside)
3-[[2-[4-[(5-nitropyridin-2-yl)amino]phenoxy]acetyl]amino]benzoic acid
1,2-Ethanediaminium,N1,N2-dimethyl-N1,N1,N2,N2-tetra-2-propen-1-yl-, bromide (1:2)
ARTEFLENE
C19H18F6O3 (408.11600699999997)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
4-[4,5-DIHYDRO-5-(1H-INDOL-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-BENZENESULFONAMIDE
4-(2-Bromo-5-fluorophenoxy)-1-[5-(2H-tetrazol-5-yl)-3-isoxazolyl]piperidine
C15H14BrFN6O2 (408.03455759999997)
Elfazepam
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Cyclooctadiene(hydroquinone)rhodium(I)tetrafluoroborate
1-((2-(6-BROMOQUINOLIN-4-YL)-1-(PYRIDIN-2-YL)ETHYLIDENE)AMINO)PYRROLIDIN-2-ONE
sym-Trimethyltriphenylcyclo trisiloxane
C21H24O3Si3 (408.10331940000003)
1-[2,6-DICHLORO-4-(FLUOROMETHYL)PHENYL]-3-(2-METHYLPROPYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID ETHYL ESTER
1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-8,8-dimethoxyoctane
C10H9F13O2 (408.03949299999994)
N,N-Dimethyl-2,7-diazapyrenium difluoroborate
C16H14B2F8N2 (408.12152799999996)
2,6-dimethoxy-4-methyl-8-nitro-5-[3-(trifluoromethyl)phenoxy]quinoline
Methanone, (3,5-dimethyl-4-isoxazolyl)[4-[4-(methylsulfonyl)-2-nitrophenyl]-1-piperazinyl]-
C17H20N4O6S (408.11035000000004)
Zinc acexamate
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
2-(4-(1-(QUINOLIN-6-YLMETHYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRAZIN-6-YL)-1H-PYRAZOL-1-YL)ETHANOL HYDROCHLORIDE
2-BENZAMIDO-3-(4-(N,N-BIS-(2-CHLOROETHYL)AMINO)PHENYL)PROPIONIC ACID
omapatrilat
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
1,4-Bis(7-chloroquinolin-4-yl)piperazine
C22H18Cl2N4 (408.09084479999996)
3,9-dibenzyl-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 3,9-dioxide
tesaglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist
tert-Butyl-4-[3-bromo-5-(trifluoromethyl)-phenyl]-1-piperazine Carboxylate
4-(2,3-Dichloro-phenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-(2-cyano-ethyl) ester 5-methyl ester
C19H18Cl2N2O4 (408.06435680000004)
1-Methyl-1-propylpyrrolidinium bis(trifluoromethanesulfonyl)imide
4-(chloromethyl)-6,8-difluoro-7-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
N-(4-Chloro-2-methylphenyl)-2-[(4-chloro-2-nitrophenyl)azo]-3-oxobutanamide
(S)-2-[(S)-(4-nitro-phenoxy)-phenoxy-phosphorylamino]propionic acid isopropyl ester
2-(4-Methoxybenzyl)-2-[4-(4-methoxybenzyloxy)phenyl]acetic acid
Contezolid
D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C258 - Antibiotic
Leriglitazone hydrochloride
C19H21ClN2O4S (408.0910496000001)
C78272 - Agent Affecting Nervous System Leriglitazone (MIN-102; Hydroxypioglitazone) hydrochloride, a metabolite of pioglitazone. Leriglitazone hydrochloride PioOH is a PPARγ agonist, stabilizes the PPARγ activation function-2 (AF-2) co-activator binding surface and enhances co-activator binding, affording slightly better transcriptional efficacy. Leriglitazone hydrochloride binds to the PPARγ C-terminal ligand-binding domain (LBD) with a Ki of 1.2 μM，Leriglitazone induces transcriptional efficacy of the PPARγ (LBD) with an EC50 of 680 nM[1].
N-{(E)-[3-(benzyloxy)phenyl]methylidene}-4-bromobenzohydrazide
C21H17BrN2O2 (408.04733219999997)
N-[(2-chlorophenyl)methyl]-2-[7-oxo-3-(phenylmethyl)-6-triazolo[4,5-d]pyrimidinyl]acetamide
(1R)-N,6-Dihydroxy-7-methoxy-2-[(4-methoxyphenyl)sulfonyl]-1,2,3,4-tetrahydroisoquinoline-1-carboxamide
C18H20N2O7S (408.09911700000004)
Ethyl Biscoumacetate
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
N-(4-chloro-2-methylphenyl)-3-[4-(2-methylpropylsulfamoyl)phenyl]propanamide
4-[(E)-2-[2,4-bis(trifluoromethyl)phenyl]ethenyl]-4,8-dimethyl-2,3-dioxabicyclo[3.3.1]nonan-7-one
C19H18F6O3 (408.11600699999997)
N-[5-(1,3-benzothiazol-2-yl)-2-chlorophenyl]-1,3-benzodioxole-5-carboxamide
C21H13ClN2O3S (408.0335378000001)
N-[2-[[1-(4-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinyl]thio]-1-oxoethyl]-2-furancarbohydrazide
C19H16N6O3S (408.10045460000003)
4-dimethoxyphosphoryl-2-(1-naphthalenyl)-N-(phenylmethyl)-5-oxazolamine
C22H21N2O4P (408.12388760000005)
(6E)-6-(3-ethoxy-4-hydroxybenzylidene)-2-(ethylsulfonyl)-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
2-[(5,6-dithiophen-2-yl-1,2,4-triazin-3-yl)oxy]-N-methyl-N-phenylacetamide
C20H16N4O2S2 (408.07146359999996)
6-(4,5-dihydrothiazol-2-ylthio)-N2,N4-bis(2-methylphenyl)-1,3,5-triazine-2,4-diamine
N-(1,3-benzodioxol-5-yl)-2-[2-(3-chloro-4-methylanilino)-2-oxoethyl]sulfinylacetamide
C18H17ClN2O5S (408.05466620000004)
3-(4-chlorophenyl)-4-[(E)-(3,5-dimethyl-1-phenylpyrazol-4-yl)methylideneamino]-1H-1,2,4-triazole-5-thione
4-methoxy-N-[[1-[(3-methyl-2-thiophenyl)-oxomethyl]-3-piperidinyl]methyl]benzenesulfonamide
4-[(2-chloro-6-fluorophenyl)-oxomethyl]-7-methyl-5-phenyl-3,5-dihydro-1H-1,4-benzodiazepin-2-one
C23H18ClFN2O2 (408.10407699999996)
2-Amino-4-[5-methyl-2-(methylthio)-3-thiophenyl]-5-oxo-1-(3-pyridinyl)-4,6,7,8-tetrahydroquinoline-3-carbonitrile
rel-3-((1S,2S,4R,6R,7S,9R,11R,12R)-2-Bromo-12-chloro-7-methyl-5,8,14-trioxa-tricyclo[9.2.1.0[4,6]]tetradec-9-yl)-acrylic acid methyl ester
C16H22BrClO5 (408.03390520000005)
A natural product found in Laurencia marilzae.
[4-(5-hydroxy-7-methoxy-8-methyl-4-oxo-4H-chromen-3-yl)-2-methoxyphenyl]oxidanesulfonic acid
C18H16O9S (408.05150060000005)
4-phenyl-N-[6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-yl]-2-thiazolamine
3,4,5-Trihydroxy-6-[2-oxo-6-(3-oxobutyl)chromen-7-yl]oxyoxane-2-carboxylic acid
6-[3-[(E)-but-1-enyl]-5-hydroxy-1-oxoisochromen-6-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[3-(3-Ethyloxiran-2-yl)-1-oxoisochromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
3,4,5-trihydroxy-6-[[6-[(E)-2-methoxyethenyl]-2-oxochromen-7-yl]methoxy]oxane-2-carboxylic acid
[2-ethoxy-6-nitro-4-[(E)-(5-oxo-2-prop-2-enylsulfanyl-1,3-thiazol-4-ylidene)methyl]phenyl] acetate
2-(9-hydroxy-2-oxo-8,9-dihydrouro[2,3-h]chromen-8-yl)propan-2-yl (E)-3-(4-hydroxyphenyl)prop-2-enoate
6-[3-[(E)-but-1-enyl]-6-hydroxy-1-oxoisochromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[3-[(E)-but-1-enyl]-7-hydroxy-1-oxoisochromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
3,4,5-trihydroxy-6-[6-[(E)-2-methoxyethenyl]-7-methyl-2-oxochromen-3-yl]oxyoxane-2-carboxylic acid
2-(4-Bromophenyl)-2-oxoethyl 12-oxododec-9(Z)-enoate
glucotropeolin(1-)
An aralkylglucosinolate that is the conjugate base of glucotropeolin; major species at pH 7.3.
CCG-203971
CCG-203971 is a second-generation Rho/MRTF/SRF pathway inhibitor. CCG-203971 potently targets RhoA/C-activated SRE-luciferase (IC50 =6.4 μM). CCG-203971 inhibits PC-3 cell migration with an IC50 of 4.2 μM. Potential anti-metastasis Agent[1][2].
γ-Glu-Phe (TFA)
C16H19F3N2O7 (408.11442999999997)
γ-Glu-Phe TFA (γ-Glutamylphenylalanine TFA) is synthesized by Bacillus amyloliquefaciens (GBA) and Aspergillus oryzae (GAO). γ-Glu-Phe TFA or the post-enzymatic reaction mixture enhances the umami intensity of commercial soy sauce and model chicken broth[1].
(2r,3r,4r,5r)-4-hydroxy-2-(4-hydroxy-2-oxopyrimidin-1-yl)-5-(hydroxymethyl)oxolan-3-yl 4-hydroxy-2-methoxy-6-methylbenzoate
C18H20N2O9 (408.11687500000005)
6,7-dimethoxy-7',7'-dimethyl-2h-spiro[1-benzopyran-3,2'-furo[2,3-f]chromene]-3',4-dione
6-(3-hydroxyprop-1-en-2-yl)-16,17-dimethoxy-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),3,8,10,14,16,18-heptaen-12-one
9-formyl-6-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-(4-hydroxyphenyl)acetate
(1s,2r,4s,5r,14r,17r)-5-[(2s)-2-hydroxy-1-[(r)-methanesulfinyl]propan-2-yl]-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadeca-8,12-diene-7,15-dione
2-[2-(3,5-dihydroxybenzoyl)-3,5-dihydroxyphenoxy]-6-methyloxane-3,4,5-triol
(1s,4as,5r,7r,7as)-5,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
1,3,4,6,7-pentahydroxy-2-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]xanthen-9-one
2,3,7-trihydroxy-3-(hydroxymethyl)-6-methoxy-1-(3,4,5-trihydroxyphenyl)-1,4-dihydronaphthalene-2-carboxylic acid
8,8,8-trichloro-2,7-dimethyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
5-(1,2-dihydroxyethyl)-4a-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h-pyrano[3,4-c]pyran-1-one
(2s,3r,4r,5r,6s)-2-[2-(3,5-dihydroxybenzoyl)-3,5-dihydroxyphenoxy]-6-methyloxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-[3,5-dihydroxy-4-(3-hydroxybenzoyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,2r,5r,14s,17r)-5-[(2r)-2-hydroxy-1-[(s)-methanesulfinyl]propan-2-yl]-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadeca-8,12-diene-7,15-dione
(2r,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl 4-hydroxy-2-methoxy-6-methylbenzoate
C18H20N2O9 (408.11687500000005)
(1s,2r,4s,5r,10s,14s,17r)-5-[(2r)-2-hydroxy-1-methanesulfinylpropan-2-yl]-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadeca-8,12-diene-7,15-dione
(2s,14r,28r)-28-hydroxy-4,11,15,22-tetraazaheptacyclo[13.11.1.1²,¹⁴.0³,¹².0⁵,¹⁰.0¹⁶,²¹.0²³,²⁷]octacosa-1(27),3(12),4,7,9,16,18,20,22,24-decaene-6,26-dione
C24H16N4O3 (408.12223459999996)